{"filing":{"accession_number":"0001434265-26-000120","cik":"0001434265","ticker":"GNMSF","company_name":"GENMAB A/S","form":"6-K","filing_date":"2026-09-08","report_date":"2026-09-08","primary_document":"gmab_20260908x6k2.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1434265/000143426526000120/gmab_20260908x6k2.htm"},"events":[{"id":32104,"run_id":29493,"accession_number":"0001434265-26-000120","anchor_item_number":"EX-99.1","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"Genmab announces a capital increase of 28,011 shares resulting from employee warrant exercises, with proceeds of approximately DKK 44.3 million. Although the increase represents only ~0.04% of share capital, employee warrant exercises constitute a dilutive issuance of equity securities. The disclosure of specific exercise prices (ranging from DKK 1,334.50 to DKK 1,948.00) and the cash proceeds confirm this is a material equity event that would affect shareholder ownership percentages and warrant holders' compensation arrangements.","company_name":"GENMAB A/S","ticker":"GNMSF","filing_date":"2026-09-08","form":"6-K","submitted_at":null,"items":[{"id":35191,"accession_number":"0001434265-26-000120","item_number":"EX-99.1","item_title":"gmab_20260908xex99d12.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Genmab announces a capital increase of 28,011 shares resulting from employee warrant exercises, with proceeds of approximately DKK 44.3 million. Although the increase represents only ~0.04% of share capital, employee warrant exercises constitute a dilutive issuance of equity securities. The disclosure of specific exercise prices (ranging from DKK 1,334.50 to DKK 1,948.00) and the cash proceeds confirm this is a material equity event that would affect shareholder ownership percentages and warrant holders' compensation arrangements.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-09T10:01:59.716704+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35191,"accession_number":"0001434265-26-000120","item_number":"EX-99.1","item_title":"gmab_20260908xex99d12.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Genmab announces a capital increase of 28,011 shares resulting from employee warrant exercises, with proceeds of approximately DKK 44.3 million. Although the increase represents only ~0.04% of share capital, employee warrant exercises constitute a dilutive issuance of equity securities. The disclosure of specific exercise prices (ranging from DKK 1,334.50 to DKK 1,948.00) and the cash proceeds confirm this is a material equity event that would affect shareholder ownership percentages and warrant holders' compensation arrangements.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-09T10:01:59.716704+00:00","company_name":"GENMAB A/S","ticker":"GNMSF","filing_date":"2026-09-08"}]}